LIVE @ #TCT2018: IMPERIAL H2H Trial Results: Statistically significant difference in primary patency with Eluvia DES 88.5% vs ZilverPTX 79.5% at 12 months #EluviaDES#IMPERIAL
Thank you @mmamas1973 for all the encouragement ππΌππΌππΌ! It means a lot to me!!I will miss meeting you at #TCT18π but hope to meet you sometime soon and collaborate with you one day πππ½
In reply to
@mmamas1973, @adityadoc1, @purviparwani, @mirvatalasnag, @Pooh_Velagapudi, @iamritu, @DrToniyaSingh, @DrMarthaGulati, @TCTConference, @mmamas1973
This is a simulator to train clinicians how to use an ECMO system. It is being displayed by Abiomed Sinulation Inc. on the show floor of the 2018 Transcatheter Cardiovascular Therapeutics (TCT) this weekend.
#TCT2018#TCT#TCT18#ECMO#cathlab
Wow. Never thought Iβd see such optimism from industry about working with the FDA. βCan we keep up with the options the FDA has for us?β #TCTConference#TCT18
